Clayton Partners’s Safeguard Scientifics, Inc. SFE Stock Holding History

Clayton Partners’s Portfolio SFE Stock Details SFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-449,136	Closed	-$337K	–	39
2024 Q1	$337K	Buy	+449,136	New	+$313K	0.29%	34
2023 Q3	–	Sell	-90,719	Closed	-$150K	–	42
2023 Q2	$150K	Sell	90,719 -52,630	-37%	-$91.9K	0.13%	33
2023 Q1	$247K	Buy	143,349 +19,429	+16%	+$53.6K	0.24%	29
2022 Q4	$384K	Sell	123,920 -177,058	-59%	-$595K	0.36%	29
2022 Q3	$1.12M	Sell	300,978 -70,649	-19%	-$284K	1.27%	26
2022 Q2	$1.39M	Buy	371,627 +74,561	+25%	+$312K	1.5%	24
2022 Q1	$1.55M	Buy	297,066 +52,172	+21%	+$316K	1.31%	28
2021 Q4	$1.8M	Sell	244,894 -199,229	-45%	-$1.56M	1.57%	29
2021 Q3	$3.94M	Sell	444,123 -411,998	-48%	-$3.3M	3.77%	8
2021 Q2	$6.64M	Buy	856,121 +155,614	+22%	+$1.06M	5.58%	4
2021 Q1	$4.78M	Buy	+700,507	New	+$5.09M	4.61%	7

Other funds holding SFE

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Clayton Partners's SFE Position: Q2 2024 in Review

Clayton Partners sold out of Safeguard Scientifics, Inc. (SFE) in Q2 2024, closing a stake of 449,136 shares — an estimated $337K sold.

Clayton Partners first reported a position in SFE in Q1 2021 and held it in 11 quarters. The position peaked at $6.64M in Q2 2021. 1 fund tracked by Wall St. Rank holds SFE as of Q2 2024.

Clayton Partners reported no remaining Safeguard Scientifics, Inc. position as of Q2 2024 after selling out during the quarter.
Clayton Partners sold 449,136 Safeguard Scientifics, Inc. shares in Q2 2024, an estimated $337K.
Clayton Partners first reported a position in Safeguard Scientifics, Inc. in Q1 2021 and held it in 11 quarters.
Clayton Partners's Safeguard Scientifics, Inc. position peaked at $6.64M in Q2 2021.
1 fund tracked by Wall St. Rank held Safeguard Scientifics, Inc. as of Q2 2024.

Based on Clayton Partners's 13F filing for Q2 2024, filed 13 Aug 2024.